HUP9902149A3 - 1-methylcarbapenem derivatives with antibacterial activity, use thereof, pharmaceutical compositions containing these compounds - Google Patents

1-methylcarbapenem derivatives with antibacterial activity, use thereof, pharmaceutical compositions containing these compounds

Info

Publication number
HUP9902149A3
HUP9902149A3 HU9902149A HUP9902149A HUP9902149A3 HU P9902149 A3 HUP9902149 A3 HU P9902149A3 HU 9902149 A HU9902149 A HU 9902149A HU P9902149 A HUP9902149 A HU P9902149A HU P9902149 A3 HUP9902149 A3 HU P9902149A3
Authority
HU
Hungary
Prior art keywords
compounds
pharmaceutical compositions
compositions containing
antibacterial activity
methylcarbapenem derivatives
Prior art date
Application number
HU9902149A
Other languages
English (en)
Original Assignee
Sankyo Company Ltd Chuo Ku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Ltd Chuo Ku filed Critical Sankyo Company Ltd Chuo Ku
Publication of HUP9902149A2 publication Critical patent/HUP9902149A2/hu
Publication of HUP9902149A3 publication Critical patent/HUP9902149A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9902149A 1996-04-26 1997-04-25 1-methylcarbapenem derivatives with antibacterial activity, use thereof, pharmaceutical compositions containing these compounds HUP9902149A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10736496 1996-04-26

Publications (2)

Publication Number Publication Date
HUP9902149A2 HUP9902149A2 (hu) 1999-10-28
HUP9902149A3 true HUP9902149A3 (en) 2002-01-28

Family

ID=14457217

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902149A HUP9902149A3 (en) 1996-04-26 1997-04-25 1-methylcarbapenem derivatives with antibacterial activity, use thereof, pharmaceutical compositions containing these compounds

Country Status (18)

Country Link
US (1) US5977097A (hu)
EP (1) EP0900797B1 (hu)
KR (1) KR20000064997A (hu)
CN (1) CN1093861C (hu)
AT (1) ATE222588T1 (hu)
AU (1) AU710881B2 (hu)
CA (1) CA2252723A1 (hu)
CZ (1) CZ342098A3 (hu)
DE (1) DE69714841T2 (hu)
DK (1) DK0900797T3 (hu)
ES (1) ES2180977T3 (hu)
HK (1) HK1018260A1 (hu)
HU (1) HUP9902149A3 (hu)
NO (1) NO312900B1 (hu)
NZ (1) NZ332453A (hu)
PT (1) PT900797E (hu)
RU (1) RU2162088C2 (hu)
WO (1) WO1997041123A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ324447A (en) * 1995-12-21 1999-08-30 Sankyo Co 1-methyl-carbapenem substituted by a 4-pyrrolidinylthio group and medicaments
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
JP2003502373A (ja) * 1999-06-23 2003-01-21 メルク エンド カムパニー インコーポレーテッド インテグリン受容体アンタゴニスト
ES2368997T3 (es) * 2001-09-26 2011-11-24 Merck Sharp & Dohme Corp. Procedimiento de fabricación de compuestos de carbapenem.
JPWO2008026527A1 (ja) * 2006-08-28 2010-01-21 株式会社カネカ ３−シアノピロリジン誘導体およびその塩の製造方法
CN101357917B (zh) * 2007-06-22 2011-03-23 山东轩竹医药科技有限公司 含有甲酰肼基的碳青霉烯化合物
CN101367809B (zh) * 2007-06-28 2011-04-27 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰肼的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
ATE114654T1 (de) * 1988-04-01 1994-12-15 Sankyo Co 2-(heterocyclylthio)carbapenemderivate, deren herstellung und deren verwendung als antibiotika.
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
JPH023687A (ja) * 1988-06-22 1990-01-09 Sankyo Co Ltd １−メチルカルバペネム誘導体
JPH04211083A (ja) * 1990-02-23 1992-08-03 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
RU2093514C1 (ru) * 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
JP3411589B2 (ja) * 1992-05-11 2003-06-03 第一製薬株式会社 カルバペネム誘導体
JP3344662B2 (ja) * 1992-09-14 2002-11-11 三共株式会社 カルバペネム−３−カルボン酸誘導体
JPH06199860A (ja) * 1992-09-16 1994-07-19 Sankyo Co Ltd カルバペネム誘導体
JPH07228570A (ja) * 1993-12-22 1995-08-29 Sankyo Co Ltd ４−メルカプトピロリジン誘導体
JP3199300B2 (ja) * 1994-05-09 2001-08-13 三共株式会社 １−メチルカルバペネム誘導体
JPH0848667A (ja) * 1994-06-03 1996-02-20 Sankyo Co Ltd ４−メルカプトピロリジン誘導体

Also Published As

Publication number Publication date
ES2180977T3 (es) 2003-02-16
DK0900797T3 (da) 2002-09-09
AU710881B2 (en) 1999-09-30
CN1223655A (zh) 1999-07-21
US5977097A (en) 1999-11-02
DE69714841D1 (de) 2002-09-26
PT900797E (pt) 2002-11-29
WO1997041123A1 (fr) 1997-11-06
RU2162088C2 (ru) 2001-01-20
NO312900B1 (no) 2002-07-15
EP0900797A1 (en) 1999-03-10
AU2407697A (en) 1997-11-19
DE69714841T2 (de) 2003-05-28
NO984948D0 (no) 1998-10-23
HK1018260A1 (en) 1999-12-17
HUP9902149A2 (hu) 1999-10-28
EP0900797A4 (en) 2000-07-19
CN1093861C (zh) 2002-11-06
NO984948L (no) 1998-12-21
CA2252723A1 (en) 1997-11-06
NZ332453A (en) 2000-09-29
KR20000064997A (ko) 2000-11-06
ATE222588T1 (de) 2002-09-15
CZ342098A3 (cs) 1999-02-17
EP0900797B1 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
HUP9701169A3 (en) Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
HUP9901590A3 (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives, use thereof, pharmaceutical compositions containing these compounds
HUP9901037A3 (en) Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds
IL134961A0 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP0102453A3 (en) Adenosine derivatives, their use and pharmaceutical compositions containing the compounds
HUP0102930A3 (en) Antiviral macrocyclic compounds, pharmaceutical compositions containing them and their use
HUP0200709A3 (en) Triazole compounds with dopamine-d3-receptor affinity, pharmaceutical compositions containing them and their use
HUP9701194A3 (en) 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9901184A3 (en) Antibacterial benzoxazine and pyrido-oxazine derivatives, intermediates, pharmaceutical compositions containing these compounds, preparation and use thereof
HUP9900975A3 (en) Quinoxalinedione derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
HUP0203505A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
IL112443A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
HUP9904682A3 (en) Phenyloxazole and -thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0203722A3 (en) Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP9902166A3 (en) Substituted benzamide derivatives having anticonvulsant activity, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9902668A3 (en) Piperazine derivatives, pharmaceutical compositions containing them and their use